Tag Archives: pharmaceuticals
Responding to the Opioid Epidemic
Matthew Herder considers possible regulatory responses to the opioid epidemic that aim to recover health care costs, compensate survivors, or prosecute pharmaceutical companies.
Clinical Trial Disaster in France
Jonathan Kimmelman comments on the recent phase 1 clinical research trial that left one healthy volunteer brain dead and five others hospitalized.
Enacting Pharmaceutical Transparency – Who, What, How, When, & Why
Matthew Herder shares a template letter that physicians, researchers, civil society groups, investigative journalists, and others can use to gain access to unpublished pharmaceutical safety and effectiveness data.
The Opacity of Bill C-17’s Transparency Amendments
Matthew Herder says it is unclear whether the ‘Protecting Canadians from Unsafe Drugs Act (Vanessa’s Law)’ will provide greater transparency in Canadian drug regulation.
Impact Ethics 